Table 3.
Characteristics of patients alive and deceased within 24 h after transport
| Patients alive 24 h after transport (n=330) | Patients deceased within 24 h after transport (n=14) | p Value | |
|---|---|---|---|
| Age (SD) | 58 (16.6) | 68 (7.5) | <0.001 |
| Male sex (%) | 227 (68.5) | 9 (64.3) | 0.722 |
| SOFA score before transport (SD/range) | 8.6 (4/0–19) | 12.3 (3.5/9–20) | <0.001 |
| Need for higher level ICU or advanced therapy (%) | 206 (62.4) | 12 (85.7) | 0.076 |
| Critical events (%) | 21 (6.4) | 1 (7.1) | 0.611 |
| Total transport time in hours (SD/range) | 5.6 (1.9/1.5–11.5) | 5.5 (1.7/4–8.5) | 0.850 |
| Median days of hospital admission before transport (range) | 4 (0–244) | 4 (0–19) | 0.072* |
| P/F ratio (SD) | 249 (113) | 192 (96) | 0.064 |
| Use of continuous vasoactive medication (%) | 142 (43.0) | 10 (71.3) | 0.036 |
| pH at time of request for transport (SD) | 7.38 (0.09) | 7.23 (0.18) | 0.011 |
| Cardiac diagnosis (%) | 75 (22.7) | 9 (64.3) | 0.001 |
| Additional medical devices (%) | 19 (5.8) | 3 (21.4) | 0.052 |
| Short-term cardiac assist devices (%) | 11 (3.3) | 3 (21.4) | 0.015 |
| Invasive mechanical ventilation (%) | 298 (90.3) | 13 (92.9) | >0.999 |
| Non-invasive ventilation (%) | 5 (1.5) | 1 (7.1) | 0.222 |
| Oxygen supply nasal or mask (%) | 27 (8.2) | 0 (0) | 0.613 |
*Mann-Whitney U test.
Total transport time: departure MICU team from our unit until return of the team plus time for updating the trolley.
Vasoactive medication: norepinephrine, dobutamine, nitroglycerine.
Cardiac diagnosis: CPR, severe valve dysfunction, cardiogenic shock, myocardial infarction.
Additional medical devices: V-V and V-A ECMO, IABP, NO.
Short-term cardiac assist devices: V-A ECMO or IABP.
CPR, cardiopulmonary resuscitation; ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon counter pulsation; ICU, intensive care unit; MICU, mobile intensive care unit; NO, nitric oxide; P/F, PaO2/FiO2 ratio; SOFA, Sequential Organ Failure Assessment; V-A ECMO, veno-arterial ECMO; V-V ECMO, veno-venous ECMO.